CGON investor plans sale of 25,989 shares

CGON has a planned sale of common stock reported by a shareholder.

Rhea-AI Filing Summary

CGON has a planned sale of common stock reported by a shareholder. The filing lists 25,989 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $1,973,970.86, against 88,640,375 common shares outstanding, with an expected sale date of 08/13/2026 on NASDAQ.

The filing also details multiple open-market sales of common shares by Ambaw Bellete during the past three months, including 75,000 shares for $5,672,212.50 on 08/06/2026 and several other transactions ranging from a few thousand to 50,000 shares each.

Key Figures

Planned shares to be sold: 25,989 shares Aggregate market value of planned sale: $1,973,970.86 Common shares outstanding: 88,640,375 shares +3 more

6 metrics

Planned shares to be sold 25,989 shares Common stock listed for sale with expected date 08/13/2026

Aggregate market value of planned sale $1,973,970.86 Value of 25,989 common shares to be sold

Common shares outstanding 88,640,375 shares Outstanding CGON common shares referenced in the notice

Sale on 08/12/2026 32,137 shares for $2,526,514.53 Common stock sale by Ambaw Bellete

Sale on 08/11/2026 50,000 shares for $3,810,255.00 Common stock sale by Ambaw Bellete

Sale on 08/06/2026 75,000 shares for $5,672,212.50 Common stock sale by Ambaw Bellete

Key Terms

Stock Option Exercise, Executive Financial Services, Securities Sold During The Past 3 Months

3 terms

Stock Option Exercise financial

"Common | 08/13/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What volume of CGON common stock is planned for sale in this Form 144?

The filing indicates a planned sale of 25,989 CGON common shares with an aggregate market value of $1,973,970.86, expected to be sold on 08/13/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many CGON shares are outstanding according to this Form 144?

The document states that there are 88,640,375 CGON common shares outstanding. This figure provides context for the relative size of the planned 25,989-share sale reported in the notice.

Which broker is handling the planned CGON stock sale?

The planned sale of 25,989 CGON common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, with the sale expected on 08/13/2026 on NASDAQ.

What recent CGON stock sales by Ambaw Bellete are disclosed?

Ambaw Bellete is shown selling CGON common shares on multiple dates, including 75,000 shares for $5,672,212.50 on 08/06/2026 and 50,000 shares for $3,810,255.00 on 08/11/2026, among other transactions.

Does the Form 144 for CGON involve a stock option exercise?

Yes. The securities to be sold include common stock related to a Stock Option Exercise, with 25,989 shares to be sold for cash on or about 08/13/2026, as indicated in the filing details.

On which market is the planned CGON sale expected to occur?

The planned sale of 25,989 CGON common shares associated with a stock option exercise is listed as occurring on NASDAQ on or about 08/13/2026, according to the transaction information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 05:08 PM Accepted by SEC EDGAR 08/13/2026 - 05:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007090
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG ONCOLOGY, INC.
SEC File Number	001-41925
Address of Issuer	3000 Pegasus Park Drive SUITE 1640 Dallas TEXAS 75247
Phone	(949) 409-3700
Name of Person for Whose Account the Securities are To Be Sold	AMBAW BELLETE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25989	1973970.86	88640375	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2026	Stock Option Exercise	Issuer			25989	08/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/12/2026	32137	2526514.53
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/11/2026	50000	3810255.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/10/2026	50000	3770580.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/07/2026	9250	696062.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/06/2026	75000	5672212.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/05/2026	25000	1837500.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/29/2026	4303	316270.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/28/2026	50000	3625195.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/27/2026	50000	3627995.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/23/2026	50000	3588620.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/15/2026	52438	3816007.65

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ambaw Bellete
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)